gip glp 1 and GLP‐1, the two incretin hormones: Similarities and differences GIP Receptor Agonism Attenuates GLP-1

31.2% (n=48) of patients receiving epoetin alfa achieved the primary endpoint of RBC-TI of at least 12 weeks with concurrent mean Hb increase of at least 1.5 g/dL within the first 24 weeks (p 10%) adverse reactions were diarrhea, fatigue, hypertension, peripheral edema, nausea, and dyspnea

With chronic administration of glucagon-containing co-agonists, the catabolism of lean mass (i.e

Author contributions RN: Conceptualization, Data curation, Formal Analysis, Methodology, Visualization, Writingoriginal draft, Writingreview and editing

Obesity (PMC), 2025

34 Fortunately, there is no clear evidence that tirzepatide increases the risk of atrial fibrillation